Last reviewed · How we verify

NCT06734416

Evaluation of the Role of Brain Natriuretic Peptide in Acute Coronary Syndrome .

Not yet recruiting Last updated 16 December 2024
What this trial tests

trial in Acute Coronary Syndromes in 100 participants. Not yet recruiting.

Timeline
1 January 2025
Primary endpoint
1 January 2026
1 March 2026

Quick facts

Lead sponsorAssiut University
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment100
Start date1 January 2025
Primary completion1 January 2026
Estimated completion1 March 2026

Conditions studied

Sponsor

Assiut University

Who can join

18 and older, any sex, with Acute Coronary Syndromes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The measurements of the natriuretic peptide are useful and beneficial for risk stratification irrespective of the cause during admission time or during hospital stay course. the aim of the study is to Assessment of the role of Brain natriuretic peptide in diagnosis of acute coronary syndrome . Evaluation of the relation of Brain natriuretic peptide to the severity and occurrence of complications in acute coronary syndrome .

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Acute Coronary Syndromes

Currently open trials in the same condition.

Other Assiut University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06734416.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing